Russell Investments Group Ltd. Raises Holdings in Nature’s Sunshine Products, Inc. $NATR

Russell Investments Group Ltd. boosted its stake in shares of Nature’s Sunshine Products, Inc. (NASDAQ:NATR) by 351.2% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 12,398 shares of the company’s stock after acquiring an additional 9,650 shares during the quarter. Russell Investments Group Ltd. owned 0.07% of Nature’s Sunshine Products worth $156,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently bought and sold shares of the stock. Dimensional Fund Advisors LP boosted its holdings in Nature’s Sunshine Products by 3.7% during the 4th quarter. Dimensional Fund Advisors LP now owns 856,701 shares of the company’s stock valued at $12,560,000 after acquiring an additional 30,464 shares during the period. Skylands Capital LLC lifted its holdings in Nature’s Sunshine Products by 1.7% in the 1st quarter. Skylands Capital LLC now owns 431,800 shares of the company’s stock worth $5,419,000 after buying an additional 7,209 shares during the period. Northern Trust Corp lifted its holdings in Nature’s Sunshine Products by 2.7% in the 4th quarter. Northern Trust Corp now owns 119,005 shares of the company’s stock worth $1,745,000 after buying an additional 3,174 shares during the period. Millennium Management LLC purchased a new stake in Nature’s Sunshine Products in the 4th quarter worth approximately $1,135,000. Finally, Ameriprise Financial Inc. lifted its holdings in Nature’s Sunshine Products by 16.8% in the 4th quarter. Ameriprise Financial Inc. now owns 51,182 shares of the company’s stock worth $750,000 after buying an additional 7,348 shares during the period. 79.40% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, major shareholder Fosun Pharmaceutical Shanghai sold 2,854,607 shares of the business’s stock in a transaction on Friday, June 27th. The stock was sold at an average price of $11.46, for a total value of $32,713,796.22. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CAO Jonathan David Lanoy sold 5,000 shares of the business’s stock in a transaction on Wednesday, August 13th. The stock was sold at an average price of $16.51, for a total value of $82,550.00. Following the completion of the transaction, the chief accounting officer owned 50,051 shares of the company’s stock, valued at $826,342.01. This represents a 9.08% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 2,869,603 shares of company stock valued at $32,961,680. 5.60% of the stock is currently owned by corporate insiders.

Nature’s Sunshine Products Stock Down 0.3%

NASDAQ NATR opened at $16.80 on Wednesday. Nature’s Sunshine Products, Inc. has a twelve month low of $11.01 and a twelve month high of $18.06. The firm has a market capitalization of $296.35 million, a PE ratio of 22.70 and a beta of 1.11. The stock’s 50 day moving average is $15.62 and its 200 day moving average is $14.22.

Nature’s Sunshine Products (NASDAQ:NATR) last released its quarterly earnings results on Thursday, July 31st. The company reported $0.35 earnings per share for the quarter, beating the consensus estimate of $0.16 by $0.19. Nature’s Sunshine Products had a return on equity of 10.19% and a net margin of 3.06%.The company had revenue of $114.75 million for the quarter, compared to analyst estimates of $113.10 million. Nature’s Sunshine Products has set its FY 2025 guidance at EPS.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the company. Canaccord Genuity Group increased their price objective on Nature’s Sunshine Products from $21.00 to $22.00 and gave the stock a “buy” rating in a report on Friday, August 1st. DA Davidson reiterated a “buy” rating and issued a $19.00 price objective on shares of Nature’s Sunshine Products in a report on Tuesday, June 3rd. Three investment analysts have rated the stock with a Buy rating, According to MarketBeat, Nature’s Sunshine Products currently has an average rating of “Buy” and a consensus price target of $19.67.

Nature’s Sunshine Products Company Profile

Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.